ABSK021 Food Effect Study in Healthy Subjects

Summary

This is a randomized, open-label, two-sequence, two-cycle, cross-over study to evaluate the relative bioavailability of ABSK021 after single-dose fasting and high-fat postprandial administration in healthy subjects

Timeline

Start

2022-07-23

Primary completion

2022-08-31

Completion

2023-05-26

Drugs

Indications